| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10684854 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 407 journal articles in the PubMed database | Email to a friend | | |
| Jäger E, Jäger D, Karbach J, et al.
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. [Journal Article]
J Exp Med 2000 Feb 21; 191(4):625-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Karbach J, Pauligk C, Bender A, et al.
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011. [Journal Article]
Int J Cancer 2006 Feb 1; 118(3):668-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mandic M, Castelli F, Janjic B, et al.
One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. [Journal Article]
J Immunol 2005 Feb 1; 174(3):1751-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zarour HM, Maillere B, Brusic V, et al.
NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. [Journal Article]
Cancer Res 2002 Jan 1; 62(1):213-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ohkuri T, Sato M, Abe H, et al.
Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population. [JOURNAL ARTICLE]
Cancer Sci 2007 May 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zarour HM, Storkus WJ, Brusic V, et al.
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. [Journal Article]
Cancer Res 2000 Sep 1; 60(17):4946-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gnjatic S, Atanackovic D, Jäger E, et al.
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. [Journal Article]
Proc Natl Acad Sci U S A 2003 Jul 22; 100(15):8862-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zeng G, Touloukian CE, Wang X, et al.
Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. [Journal Article]
J Immunol 2000 Jul 15; 165(2):1153-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mandic M, Almunia C, Vicel S, et al.
The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells. [Journal Article]
Cancer Res 2003 Oct 1; 63(19):6506-15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
